ENTRY       D07507            Mixture   Drug
NAME        Zidovudine and lamivudine;
            Combivir (TN);
            Lamivudine zidovudine (TN)
PRODUCT     COMBIVIR (ViiV Healthcare Company)
  GENERIC   LAMIVUDINE AND ZIDOVUDINE (Aurobindo Pharma Limited)
            LAMIVUDINE AND ZIDOVUDINE (Bryant Ranch Prepack)
            LAMIVUDINE AND ZIDOVUDINE (Bryant Ranch Prepack)
            LAMIVUDINE AND ZIDOVUDINE (Bryant Ranch Prepack)
            LAMIVUDINE AND ZIDOVUDINE (Camber Pharmaceuticals)
            LAMIVUDINE AND ZIDOVUDINE (Camber Pharmaceuticals)
            LAMIVUDINE AND ZIDOVUDINE (Exelan Pharmaceuticals)
            LAMIVUDINE AND ZIDOVUDINE (Lupin Pharmaceuticals)
            LAMIVUDINE AND ZIDOVUDINE (Macleods Pharmaceuticals Limited)
            LAMIVUDINE AND ZIDOVUDINE (NuCare Pharmaceuticals)
            LAMIVUDINE AND ZIDOVUDINE (PD-Rx Pharmaceuticals)
            LAMIVUDINE AND ZIDOVUDINE (Strides Pharma Science Limited)
            LAMIVUDINE AND ZIDOVUDINE (XLCare Pharmaceuticals)
COMPONENT   Zidovudine [DR:D00413], Lamivudine [DR:D00353]
CLASS       Antiviral
             DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
             DG03107  Anti-HIV agent
REMARK      Therapeutic category: 6250
            ATC code: J05AR01
            Product: D07507<JP/US>
EFFICACY    Antiviral
  DISEASE   HIV-1 infection [DS:H01563]
TARGET      HIV-1 reverse transcriptase [KO:K24802]
  PATHWAY   ko03230(K24802)  Viral genome structure
            ko03240(K24802)  Viral replication
            ko03250(K24802)  Viral life cycle - HIV-1
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J05 ANTIVIRALS FOR SYSTEMIC USE
               J05A DIRECT ACTING ANTIVIRALS
                J05AR Antivirals for treatment of HIV infections, combinations
                 J05AR01 Zidovudine and lamivudine
                  D07507  Zidovudine and lamivudine &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antivirals
              Anti-HIV Combinations
               Lamivudine/ Zidovudine
                D07507  Zidovudine and lamivudine
            Therapeutic category of drugs in Japan [BR:br08301]
             6  Agents against pathologic organisms and parasites
              62  Chemotherapeutics
               625  Antivirals
                6250  Antivirals
                 D07507  Zidovudine and lamivudine
            Drug groups [BR:br08330]
             Antiviral
              DG01890  Nucleoside reverse transcriptase inhibitor (NRTI)
               D07507  Zidovudine and lamivudine
              DG03107  Anti-HIV agent
               D07507  Zidovudine and lamivudine
            Drug classes [BR:br08332]
             Antiviral
              DG03107  Anti-HIV agent
               D07507  Zidovudine and lamivudine
            Antimicrobials [BR:br08307]
             Antivirals
              Genome replication inhibitor
               HIV reverse transcriptase inhibitor
                D07507  Zidovudine and lamivudine &lt;JP/US&gt;
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D07507
DBLINKS     PubChem: 51091831
///
